A Prospective, Double-blind, Randomized, Parallel, Multiple-center Study to Compare the Efficacy and Safety of 1PC002 and Atorvastatin in Taiwanese Patients With Hypercholesterolemia

Trial Profile

A Prospective, Double-blind, Randomized, Parallel, Multiple-center Study to Compare the Efficacy and Safety of 1PC002 and Atorvastatin in Taiwanese Patients With Hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jun 2013

At a glance

  • Drugs Pitavastatin (Primary) ; Atorvastatin
  • Indications Hypercholesterolaemia
  • Focus Biomarker; Registrational; Therapeutic Use
  • Sponsors Orient Pharma
  • Most Recent Events

    • 14 Jun 2013 Actual initiation date changed from Sep 2011 to Nov 2011 as reported by ClinicalTrials.gov.
    • 12 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top